Literature DB >> 10561334

Tamoxifen: too much of a good thing?

V C Jordan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10561334     DOI： 10.1200/JCO.1999.17.9.2629

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

Review 1.  Chemoprevention of breast cancer: implications for postmenopausal women.

Authors:  Carol J Fabian; Bruce F Kimler
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

Review 2.  Molecular markers for predicting response to tamoxifen in breast cancer patients.

Authors:  D R Ciocca; R Elledge
Journal:  Endocrine       Date:  2000-08       Impact factor: 3.925

3.  An alpha-fetoprotein-derived peptide reduces the uterine hyperplasia and increases the antitumour effect of tamoxifen.

Authors:  T T Andersen; J Georgekutty; L A Defreest; G Amaratunga; A Narendran; N Lemanski; H I Jacobson; J A Bennett
Journal:  Br J Cancer       Date:  2007-07-17       Impact factor: 7.640

4.  p21-activated kinase group II small compound inhibitor GNE-2861 perturbs estrogen receptor alpha signaling and restores tamoxifen-sensitivity in breast cancer cells.

Authors:  Ting Zhuang; Jian Zhu; Zhilun Li; Julie Lorent; Chunyan Zhao; Karin Dahlman-Wright; Staffan Strömblad
Journal:  Oncotarget       Date:  2015-12-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.